GSA Capital Partners’s Enzo Biochem, Inc. ENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,807
Closed -$41K 1645
2021
Q1
$41K Sell
11,807
-28,365
-71% -$98.5K 0.01% 1035
2020
Q4
$101K Sell
40,172
-26,500
-40% -$66.6K 0.02% 1097
2020
Q3
$141K Buy
66,672
+52,761
+379% +$112K 0.02% 1080
2020
Q2
$31K Buy
+13,911
New +$31K 0.02% 552
2020
Q1
Sell
-17,593
Closed -$46K 1646
2019
Q4
$46K Sell
17,593
-17,200
-49% -$45K 0.01% 1373
2019
Q3
$125K Sell
34,793
-41,107
-54% -$148K 0.02% 1253
2019
Q2
$256K Buy
75,900
+14,300
+23% +$48.2K 0.03% 1101
2019
Q1
$168K Sell
61,600
-57
-0.1% -$155 0.02% 1272
2018
Q4
$171K Hold
61,657
0.02% 1138
2018
Q3
$254K Sell
61,657
-44,043
-42% -$181K 0.01% 1398
2018
Q2
$549K Sell
105,700
-37,700
-26% -$196K 0.03% 1112
2018
Q1
$786K Buy
143,400
+2,700
+2% +$14.8K 0.04% 823
2017
Q4
$1.15M Sell
140,700
-3,391
-2% -$27.6K 0.07% 517
2017
Q3
$1.51M Sell
144,091
-27,600
-16% -$289K 0.1% 284
2017
Q2
$1.9M Sell
171,691
-145,240
-46% -$1.6M 0.12% 177
2017
Q1
$2.65M Buy
316,931
+53,831
+20% +$451K 0.14% 148
2016
Q4
$1.83M Buy
263,100
+103,292
+65% +$717K 0.11% 240
2016
Q3
$813K Buy
159,808
+55,300
+53% +$281K 0.04% 736
2016
Q2
$624K Sell
104,508
-79,519
-43% -$475K 0.03% 948
2016
Q1
$837K Sell
184,027
-75,500
-29% -$343K 0.05% 658
2015
Q4
$1.17M Sell
259,527
-16,571
-6% -$74.6K 0.06% 581
2015
Q3
$875K Buy
276,098
+31,204
+13% +$98.9K 0.04% 747
2015
Q2
$742K Buy
244,894
+138,798
+131% +$421K 0.03% 1109
2015
Q1
$313K Buy
106,096
+30,870
+41% +$91.1K 0.01% 1691
2014
Q4
$334K Buy
75,226
+61,881
+464% +$275K 0.02% 1199
2014
Q3
$69K Sell
13,345
-20,748
-61% -$107K ﹤0.01% 1643
2014
Q2
$179K Buy
+34,093
New +$179K 0.01% 1655
2014
Q1
Sell
-63,393
Closed -$185K 1837
2013
Q4
$185K Sell
63,393
-5,100
-7% -$14.9K 0.01% 1480
2013
Q3
$173K Sell
68,493
-3,700
-5% -$9.35K 0.01% 1425
2013
Q2
$150K Buy
+72,193
New +$150K 0.02% 1162